An Antibacterial and Antifouling MPC/NaSS/DMA Coating against Biofilms and Thrombi on Vascular Device Implants
Langmuir · 31.03.2026 · 42 (12) · 8907-8918
DOI: 10.1021/acs.langmuir.6c00352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, online erschienen am 20.03.2026. Verfasst von Xingxing Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Engineering, Guangdong Academy of Sciences, Guangzhou, Guangdong 510000, China. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Coated Materials, Biocompatible, Phosphorylcholine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Shantou Science and Technology Project, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The formation of pathogenic bacterial biofilms and thrombui is one of the most common causes of infections associated with medical implants. Proposing a new strategy to endow implant materials with effective antifouling and antibacterial properties, ensuring their safe and long-term use, is of great clinical significance. Therefore, an antibacterial and antifouling composite coating was proposed in this study. A zwitterionic copolymer, PSS containing MPC, NaSS, and DMA, was first prepared through free radical copolymerization. Dopamine and PSS copolymers were self-polymerized to form a composite coating, and the phenolic hydroxyl functional groups in the coating effectively chelated and reduced silver ions into silver nanoparticles. The results showed that the composite coatings all exhibited significant antifouling capabilities against proteins (BSA and BFG), platelets, and bacteria (S. aureus and E. coli). With the increased amount of MPC, specifically PVC/PSS262-Ag, the composite coating exhibited the most outstanding performance, with an antiprotein adsorption rate exceeding 90%. Cytotoxicity tests with HUVECs and rabbit blood demonstrated that the composite coating had an excellent biocompatibility. In summary, the dual antibacterial and antifouling coating proposed in this study holds great potential for application in controlling the formation of biofilms and thrombi on biomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Engineering, Guangdong Academy of Sciences, Guangzhou, Guangdong 510000, China.
- Key Laboratory of Metallurgical Equipment and Control Technology (Ministry of Education), Wuhan University of Science and Technology, Wuhan 430081, China.
- Hubei Key Laboratory of Mechanical Transmission and Manufacturing Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
- Department of Oral Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450046, China.
ORCID-Profile: Kangle Jia, Chengxiong Lin
Förderung
- Shantou Science and Technology Project
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Innovation and Entrepreneurship Team Project of Jieyang
- Guangzhou Foundation for Basic and Applied Basic Research
Zitieren
APA
Liu, X., Hu, J., Chen, X., Yu, L., Jia, K., Chu, Y., Wang, J., & Lin, C. (2026). An Antibacterial and Antifouling MPC/NaSS/DMA Coating against Biofilms and Thrombi on Vascular Device Implants. Langmuir, 42(12), 8907-8918. https://doi.org/10.1021/acs.langmuir.6c00352
Vancouver
Liu X, Hu J, Chen X, Yu L, Jia K, Chu Y, et al. An Antibacterial and Antifouling MPC/NaSS/DMA Coating against Biofilms and Thrombi on Vascular Device Implants. Langmuir. 2026;42(12):8907-8918. doi:10.1021/acs.langmuir.6c00352
BibTeX
@article{Liu2026,
author = {Liu, Xingxing and Hu, Jiafeng and Chen, Xiaojun and Yu, Longfei and Jia, Kangle and Chu, Yinlin and Wang, Jiangbo and Lin, Chengxiong},
title = {An Antibacterial and Antifouling MPC/NaSS/DMA Coating against Biofilms and Thrombi on Vascular Device Implants},
journal = {Langmuir},
year = {2026},
volume = {42},
number = {12},
pages = {8907--8918},
doi = {10.1021/acs.langmuir.6c00352}
}
EUVIMED